Laboratory Resources

Information about opioids

 

In July 2017, ExamOne announced it offers an expanded opioid panel for life insurers. For the last three decades, ExamOne has offered two main options (see table below) for full urine drug screens to help insurers identify risk in the insurance population.

These screens were developed in the 1980s and are recommended by the Substance Abuse and Mental Health Services Administration (SAMHSA, formerly the National Institute on Drug Abuse, NIDA) for the testing of certain federal employees, as well as specified Department of Transportation (DOT) regulated occupations.

The expanded panel detects semi-synthetic opioid use and includes the following drugs: codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone and heroin. As with all drug testing, positive screens are confirmed with gas chromatography/mass spectrometry (gc/ms).

 

Learn more about the risks and impacts of opioid abuse in America.

The risks of opioid for life insurers

10 facts about opioids

One in 4 individuals combine opioids and benzodiazepines

Illicit drug use in the US is at the highest rate in a decade

 


More laboratory resources

 

We are committed to providing you with the resources you need to underwrite with full confidence. This section highlights specific laboratory tests and why you should include them in your standard insurance testing panel.

 

Cotinine

Tobacco indicator
Download

Cystatin C

Kidney disease and mortality marker
Download

Expanded opioids

Prescription and drugs of abuse marker
Download

 

Hemoglobin A1c

Diabetes and mortality marker

Download

Microalbumin

Diabetes marker
Download

NT-proBNP

Congestive heart failure marker
Download

PSA

Total and free PSA
Download